Bottom line
What is PCJUX's expense ratio?
PCJUX's expense ratio is 1.35%, or about $135 a year on every $10,000 invested. That is more expensive than 92% of target-date funds we track (median 0.59%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 24, 2026
PCJUX fee table
| Net expense ratio | 1.35% |
|---|---|
| Gross expense ratio | 13.19% |
| Management fee | 0.54% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 11.52% |
| Acquired fund fees | 0.63% |
| Fee waiver / reimbursement | -11.84% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 24, 2026
What PCJUX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCJUX | $137 | $427 | $3,129 | $8,170 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.35% expense ratio costs roughly $72,500 in lost growth, versus about $33,900 for the median target-date fund (0.59%).